134 related articles for article (PubMed ID: 6117842)
41. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.
Martins JM; Kastin AJ; Banks WA
Neuroendocrinology; 1996 Apr; 63(4):338-48. PubMed ID: 8739889
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
Hagan MM; Moss DE
Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
[TBL] [Abstract][Full Text] [Related]
43. Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal man.
Ashton H; Millman JE; Telford R; Thompson JW; Davies TF; Hall R; Shuster S; Thody AJ; Coy DH; Kastin AJ
Psychopharmacology (Berl); 1977 Dec; 55(2):165-72. PubMed ID: 23563
[No Abstract] [Full Text] [Related]
44. Saturable brain-to-blood transport of endomorphins.
Kastin AJ; Fasold MB; Smith RR; Horner KA; Zadina JE
Exp Brain Res; 2001 Jul; 139(1):70-5. PubMed ID: 11482845
[TBL] [Abstract][Full Text] [Related]
45. Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats.
Hayashi T; Fischman AJ; Kastin AJ; Coy DH
Pharmacol Biochem Behav; 1984 Nov; 21(5):809-12. PubMed ID: 6151198
[TBL] [Abstract][Full Text] [Related]
46. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
Björkman S; Castensson S; Sievertsson H
J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
[TBL] [Abstract][Full Text] [Related]
47. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
Hara C; Kastin AJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
[TBL] [Abstract][Full Text] [Related]
48. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
Vivas A; Celis ME
Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
[TBL] [Abstract][Full Text] [Related]
49. Effect of Tyr-Pro-Leu-Gly-NH2 on melanotropin-stimulating hormone release in the frog and rat.
Tonon MC; Leroux P; Saulot P; Vaudry H; Coy DH; Kastin AJ
Gen Comp Endocrinol; 1983 Oct; 52(1):17-22. PubMed ID: 6138295
[TBL] [Abstract][Full Text] [Related]
50. Attenuation of morphine tolerance and dependence by alpha-melanocyte stimulating hormone(alpha-MSH).
Székely JI; Miglécz E; Dunai-Kovács Z; Tarnawa I; Rónai AZ; Gráf L; Bajusz S
Life Sci; 1979 May; 24(21):1931-8. PubMed ID: 37395
[No Abstract] [Full Text] [Related]
51. Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1.
Banks WA; Kastin AJ; Michals EA; Barrera CM
Brain Res Bull; 1990 Oct; 25(4):589-92. PubMed ID: 1980229
[TBL] [Abstract][Full Text] [Related]
52. Peptides and thermoregulation.
Yehuda S; Kastin AJ
Neurosci Biobehav Rev; 1980; 4(4):459-71. PubMed ID: 6110198
[TBL] [Abstract][Full Text] [Related]
53. The failure of L-prolyl-L-leucylglycinamide to inhibit the release of alpha-melanocyte-stimulating hormone in the rat.
Thody AJ; Lever de Vries CH; Tilders FJ
Acta Endocrinol (Copenh); 1980 Mar; 93(3):300-5. PubMed ID: 6103629
[TBL] [Abstract][Full Text] [Related]
54. Neurologically active peptides.
Barbeau A; Gonce M; Kastin AJ
Pharmacol Biochem Behav; 1976; 5(Suppl 1):159-63. PubMed ID: 13415
[TBL] [Abstract][Full Text] [Related]
55. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate.
Kastin AJ; Hahn K; Zadina JE; Banks WA; Hackler L
J Neurochem; 1995 Apr; 64(4):1855-9. PubMed ID: 7891114
[TBL] [Abstract][Full Text] [Related]
56. Synthetic MIF has no effect on beta-MSH and ACTH hypersecretion in Nelson's syndrome.
Donnadieu M; Laurent MF; Luton JP; Bricaire H; Girard F; Binoux M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1145-8. PubMed ID: 6486
[TBL] [Abstract][Full Text] [Related]
57. Naloxone-like protective effect of MIF-1 (Pro-Leu-Gly-NH2) on hemorrhagic shock.
Krause W; Nieber K; Ehrlich A; Bienert M; Oehme P
Pharmazie; 1984 May; 39(5):352-3. PubMed ID: 6147863
[No Abstract] [Full Text] [Related]
58. EEG evidence that morphine and an enkephalin analog cross the blood-brain barrier.
Kastin AJ; Pearson MA; Banks WA
Pharmacol Biochem Behav; 1991 Dec; 40(4):771-4. PubMed ID: 1687763
[TBL] [Abstract][Full Text] [Related]
59. Effects of Pro-Leu-Gly-NH2 (MIF) on the antinociceptive and thermoregulatory actions of morphine and oxotremorine.
Slater P; Dickinson SL
J Pharm Pharmacol; 1982 Feb; 34(2):113-5. PubMed ID: 6121869
[No Abstract] [Full Text] [Related]
60. MIF-1 facilitates passive avoidance retention.
Puciłowski O; Płaźnik A; Kostowski W
Pol J Pharmacol Pharm; 1982; 34(1-3):107-13. PubMed ID: 6132368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
